4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines

    公开(公告)号:US08343975B2

    公开(公告)日:2013-01-01

    申请号:US12557428

    申请日:2009-09-10

    IPC分类号: A61K31/497 C07D487/00

    CPC分类号: C07D487/04

    摘要: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are 4-amino-3-imidazoyl-pyrazolo[3,4-d]pyrimidine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.

    4-AMINO-3-(IMIDAZOLYL)-PYRAZOLO[3,4-D]PYRIMIDINES
    6.
    发明申请
    4-AMINO-3-(IMIDAZOLYL)-PYRAZOLO[3,4-D]PYRIMIDINES 有权
    4-氨基-3-(咪唑烷基) - 吡唑并[3,4-D]吡啶

    公开(公告)号:US20100069396A1

    公开(公告)日:2010-03-18

    申请号:US12557428

    申请日:2009-09-10

    CPC分类号: C07D487/04

    摘要: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are 4-amino-3-imidazoyl-pyrazolo[3,4-d]pyrimidine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.

    摘要翻译: 提供了作为CCR1受体的有效拮抗剂并具有体内抗炎活性的化合物。 该化合物是4-氨基-3-咪唑基 - 吡唑并[3,4-d]嘧啶衍生物,可用于药物组合物,治疗CCR1介导的疾病的方法,以及用于鉴定竞争性CCR1拮抗剂的测定中的对照 。